Condition: Cardiometabolic Risk Factors · Sponsor: Anhui Medical University
The goal of this randomized controlled clinical trial is to investigate the effects of vitamin D3 supplementation on cardiometabolic risk in Chinese adolescents with overweight/obesity and vitamin D deficiency. The main question it aims to answer whether vitamin D3 supplementation can improve cardiovascular metabolic health. Participants in the intervention group will receive vitamin D3. The control group will receive vitamin D placebo. Researchers will compare the change in cardiometabolic risk from baseline to post-intervention at 12 weeks between the intervention and control groups.
This description comes directly from the study's public registry record.
Puyu Su, PhD · 86-13856058551 · supuyu@ahmu.edu.cn
Puyu Su, Professor · 86-13856058551 · supuyu@ahmu.edu.cn
Always discuss trial participation with your own doctor first.
| Anhui Medical University | Anqing, Anhui, China | Recruiting |
| Anhui Medical University | Hefei, Anhui, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07053657